Cardinal Health, Inc. $CAH Shares Sold by Vontobel Holding Ltd.

Key Points

• Vontobel Holding Ltd. reduced its stake in Cardinal Health by 39.4%, owning 39,471 shares valued at $6.63 million after selling 25,610 shares in the second quarter.
• JPMorgan Chase & Co. increased its holdings by 40.0% in the first quarter, owning 4,175,992 shares valued at $575.3 million, while other institutional investors also adjusted their positions.
• Cardinal Health announced a quarterly dividend of $0.5107 per share, with an annualized yield of 1.3%, and reported earnings of $2.08 per share, surpassing consensus estimates.

Vontobel Holding Ltd. lessened its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 39.4% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 39,471 shares of the company's stock after selling 25,610 shares during the quarter. Vontobel Holding Ltd.'s holdings in Cardinal Health were worth $6,631,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. grew its position in Cardinal Health by 40.0% during the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company's stock valued at $575,327,000 after buying an additional 1,193,983 shares during the period. Northern Trust Corp lifted its holdings in Cardinal Health by 3.5% during the first quarter. Northern Trust Corp now owns 3,143,003 shares of the company's stock valued at $433,012,000 after purchasing an additional 105,154 shares in the last quarter. Wellington Management Group LLP lifted its holdings in Cardinal Health by 1,666.7% during the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company's stock valued at $328,470,000 after purchasing an additional 2,249,241 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in Cardinal Health by 3.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 1,654,036 shares of the company's stock valued at $227,877,000 after purchasing an additional 52,714 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in Cardinal Health by 0.6% during the first quarter. Dimensional Fund Advisors LP now owns 1,246,788 shares of the company's stock valued at $171,749,000 after purchasing an additional 7,940 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Trading Down 0.2%

NYSE:CAH opened at $156.86 on Friday. The company's 50-day moving average price is $152.09 and its 200-day moving average price is $151.09. The company has a market cap of $37.27 billion, a P/E ratio of 24.32, a P/E/G ratio of 1.33 and a beta of 0.71. Cardinal Health, Inc. has a twelve month low of $106.98 and a twelve month high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping the consensus estimate of $2.03 by $0.05. The firm had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company's revenue for the quarter was up .5% on a year-over-year basis. During the same period last year, the firm posted $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be paid a dividend of $0.5107 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. Cardinal Health's payout ratio is 31.63%.

Insider Activity at Cardinal Health

In other Cardinal Health news, CEO Stephen M. Mason sold 41,575 shares of Cardinal Health stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the transaction, the chief executive officer directly owned 26,085 shares of the company's stock, valued at $3,881,969.70. The trade was a 61.45% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Ola M. Snow sold 28,151 shares of Cardinal Health stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the transaction, the insider directly owned 15,431 shares in the company, valued at $2,298,293.14. This trade represents a 64.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 271,676 shares of company stock valued at $40,489,525 over the last ninety days. Corporate insiders own 0.12% of the company's stock.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. Wells Fargo & Company reaffirmed an "overweight" rating and set a $185.00 price objective (up from $183.00) on shares of Cardinal Health in a report on Wednesday, August 13th. Argus set a $189.00 price objective on shares of Cardinal Health in a report on Friday, August 22nd. Weiss Ratings reaffirmed a "buy (b)" rating on shares of Cardinal Health in a report on Wednesday. Morgan Stanley reaffirmed an "overweight" rating on shares of Cardinal Health in a report on Tuesday, August 12th. Finally, Wall Street Zen downgraded shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 2nd. Twelve analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Cardinal Health presently has a consensus rating of "Moderate Buy" and a consensus target price of $166.00.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.